Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 Next >
Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023
From Bayer
Via Business Wire
Bayer and Dollar General Partner to Increase Access to Fruit and Veggies, Celebrate National School Lunch Week
From Bayer
Via Business Wire
Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
From Bayer
Via Business Wire
The Menopause Society Annual Meeting 2023: Bayer to present latest real-world evidence of menopausal symptoms and their treatment
From Bayer
Via Business Wire
Bayer’s Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology
From Bayer
Via Business Wire
Bayer Expands Clinical Development Program Investigating Finerenone for Potential Treatment of Heart Failure
From Bayer
Via Business Wire
Bayer and Kroger Team to Help Improve Access to Health and Nutrition in Rural America
From Bayer
Via Business Wire
FieldView Rolls Out New Capabilities For Post-Harvest Analysis and Reporting
From Bayer
Via Business Wire
One in Four American Adults Would Rather Not Know They Have Cancer
From Bayer
Via Business Wire
Bayer Donates $500K to Support Maui Community After Devastating Fires
From Bayer
Via Business Wire
The Terror is Hatching: Bayer Unveils Upcoming “Rootworm Week”
From Bayer
Via Business Wire
Bayer Earns Top Score on 2023 Disability Equality Index
From Bayer
Via Business Wire
Bayer and Luke Bryan Reunite for Annual #HerestotheFarmer Campaign in Support of Feeding America and Rural Communities
From Bayer
Via Business Wire
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane
From Bayer
Via Business Wire
FDA approves Bayer’s Ultravist® (iopromide) injection for contrast-enhanced mammography
From Bayer
Via Business Wire
Bayer to Investigate Finerenone in Phase III Study in Adults With Chronic Kidney Disease Associated With Type 1 Diabetes
From Bayer
Via Business Wire
Bayer Announces Senior Bayer Representative and President of Bayer U.S.
From Bayer
Via Business Wire
Bayer Announces Changes to U.S. Country Leadership Team
From Bayer
Via Business Wire
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics
From Bayer
Via Business Wire
Latest Vitrakvi® (larotrectinib) Subgroup Analyses at ASCO 2023 Showcase Long-Term Efficacy and Safety Profile in Adult and Pediatric Patients with NTRK Gene Fusion Cancer, Across Solid Tumors
From Bayer
Via Business Wire
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
From Bayer
Via Business Wire
Bayer Launches Unit to Develop New Precision Health Consumer Products
From Bayer
Via Business Wire
Bayer Presents New Data Across Oncology Portfolio at the 2023 ASCO Annual Meeting
From Bayer
Via Business Wire
Bayer launches Seeing Red campaign around the treatment of Heavy Menstrual Bleeding (HMB)
From Bayer
Via Business Wire
Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program
From Bayer
Via Business Wire
Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncogene Amplified Cancer
From Bayer
Via Business Wire
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
From Bayer
Via Business Wire
Tickers BCYC
Bayer Opens First Co.Lab Life Science Incubator in Cambridge
From Bayer
Via Business Wire
Bayer Announces New Strategic Collaboration with New Jersey’s Leading Polytechnic Universities to Cultivate Data Science Talent in Region
From Bayer
Via Business Wire
There Is No Room for Allergy Fog This Spring Allergy Season with Claritin®
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.